Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification-Reference-Cited by-同舟云学术

Apolipoprotein C-I binds free fatty acids and reduces their intracellular esterification

Published:2007-07 Issue:6 Volume:48 Page:1353-1361
ISSN:0022-2275
Container-title:Journal of Lipid Research
language:en
Short-container-title:Journal of Lipid Research

Author:

Westerterp Marit,Berbée Jimmy F.P.,Delsing Dianne J.M.,Jong Miek C.,Gijbels Marion J.J.,Dahlmans Vivian E.H.,Offerman Erik H.,Romijn Johannes A.,Havekes Louis M.,Rensen Patrick C.N.

Publisher

Elsevier BV

Subject

Cell Biology,Endocrinology,Biochemistry

Reference45 articles.

1. Two copies of the human apolipoprotein C-I gene are linked closely to the apolipoprotein E gene;Lauer;J. Biol. Chem.,1988

2. Role of ApoCs in lipoprotein metabolism—functional differences between ApoC1, ApoC2, and ApoC3;Jong;Arterioscler. Thromb. Vasc. Biol.,1999

3. Increased response to cholesterol feeding in apolipoprotein C1-deficient mice;van Ree;Biochem. J.,1995

4. Inactivation of Apoe and Apoc1 by two consecutive rounds of gene targeting: effects on mRNA expression levels of gene cluster members;van Ree;Hum. Mol. Genet.,1995

5. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway;Jong;J. Clin. Invest.,1996

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrahepatic macrophage reprogramming associated with lipid metabolism in hepatitis B virus-related acute-on-chronic liver failure;Journal of Translational Medicine;2023-06-28

2. Evaluating the Contribution of Cell Type–Specific Alternative Splicing to Variation in Lipid Levels;Circulation: Genomic and Precision Medicine;2023-06

3. Microprotein Dysregulation in the Serum of Patients with Atrial Fibrillation;Journal of Proteome Research;2023-03-16

4. Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies;Pharmaceuticals;2022-10-18

5. Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk;Pharmacogenomics;2022-01